1. After consulting the Coordination Group, the Commission shall adopt, by means of implementing acts, detailed procedural rules for:
(a)
submission of requests from health technology developers;
(b)
the selection and consultation of stakeholder organisations and patients, clinical experts and other relevant experts in joint scientific consultation;
(c)
cooperation, in particular by exchange of information, with the European Medicines Agency on joint scientific consultations on medicinal products where a health technology developer requests the consultation to be carried out in parallel with a process for scientific advice from the European Medicines Agency;
(d)
cooperation, in particular by exchange of information, with the expert panels on the joint scientific consultations on medical devices where a health technology developer requests the consultation to be carried out in parallel with the consultation of those expert panels.
2. Implementing acts referred to in paragraph 1 of this Article shall be adopted in accordance with the examination procedure referred to in Article 33(2).